MTLN

MTLN (MOXI/Mitoregulin/MPM/LEMP) encodes a conserved ~56-amino acid micropeptide of the inner mitochondrial membrane that functions as a regulator of oxidative metabolism and respiratory efficiency (PMID:29949755, PMID:32393776). It enhances mitochondrial fatty acid β-oxidation through association with the mitochondrial trifunctional protein complex, such that loss of MTLN shifts fuel preference from fatty acids to carbohydrates and, under high-fat-diet challenge, produces obesity, elevated serum triglycerides, and depletion of TCA cycle intermediates (PMID:29949755, PMID:36174793). MTLN also constrains respiratory chain output by binding the complex I subunit NDUFA7 to inhibit complex I activity and lower the NAD+/NADH ratio (PMID:34478872). Through these effects on mitochondrial respiration it promotes myogenic differentiation — an activity rescued downstream by PGC-1α — and is required for normal skeletal muscle fiber size, regeneration, and development across species (PMID:31296841, PMID:32393776). In the heart, MTLN drives cardiomyocyte proliferation and growth by interacting with PTPMT1 to activate AKT signaling (PMID:39163918). Beyond mitochondria, MTLN undergoes T49-phosphorylation-dependent nuclear translocation upon TGF-β1 stimulation, where it bridges N-acetyltransferase 14 (Nat14) and c-Jun to activate the collagen I promoter and promote kidney fibrosis (PMID:36804379). The micropeptide self-associates into pore-like oligomeric complexes in the mitochondrial membrane [PMID:bio_10.1101_2024.07.10.601956].

1. 2018 High

   Established that MTLN is a functional mitochondrial micropeptide rather than noncoding sequence, defining its core role in fatty acid β-oxidation via the trifunctional protein complex.

   Evidence Subcellular fractionation, reciprocal Co-IP with MTP, isolated-mitochondria oxidation assays, and KO/transgenic mouse metabolic phenotyping

   PMID:29949755

   Open questions at the time

   • Whether MTLN acts catalytically or as a structural/regulatory scaffold for MTP was not resolved
   • Direct binding stoichiometry to MTP subunits not defined
2. 2019 High

   Linked MTLN's mitochondrial respiratory function to a developmental output by showing it is required for myogenic differentiation, placing it upstream of PGC-1α-driven biogenesis.

   Evidence siRNA/overexpression in C2C12, KO mouse muscle phenotyping, respiration/ATP assays, and PGC-1α epistasis rescue

   PMID:31296841

   Open questions at the time

   • Molecular link between MTLN and PGC-1α not defined
   • Whether differentiation defect is purely metabolic or signaling-dependent unclear
3. 2020 High

   Demonstrated evolutionary conservation of MTLN's myogenic function via cross-species rescue, confirming a generalizable role in muscle formation.

   Evidence Zebrafish loss-of-function rescued by mouse LEMP, Co-IP with mitochondrial proteins, satellite-cell RNA-seq

   PMID:32393776

   Open questions at the time

   • Reported plasma membrane localization not mechanistically explained
   • Identities/relevance of additional mitochondrial partners not resolved
4. 2021 High

   Identified a direct respiratory-chain target, showing MTLN binds NDUFA7 to inhibit complex I and tune the NAD+/NADH ratio, connecting it to redox balance and tumor cell behavior.

   Evidence MPM–NDUFA7 Co-IP, complex I activity and NAD+/NADH assays, NDUFA7 knockdown epistasis, NAD+ precursor rescue, migration/metastasis models, miR-17-5p binding assay

   PMID:34478872

   Open questions at the time

   • How MTLN reconciles complex I inhibition with enhanced β-oxidation/respiration is unresolved
   • Structural basis of NDUFA7 binding unknown
5. 2022 Medium

   Confirmed the whole-organism metabolic consequence of MTLN loss, establishing it as required for efficient oxidative metabolism of respiratory substrates in vivo.

   Evidence Mtln KO mice on high-fat diet with MRI fat-mass imaging and serum metabolite/TCA-intermediate measurement

   PMID:36174793

   Open questions at the time

   • No in vitro mechanistic reconstitution
   • Single-lab phenotype without orthogonal molecular mechanism
6. 2023 High

   Revealed an unexpected non-mitochondrial, transcriptional function: TGF-β1-induced, T49-phosphorylation-dependent nuclear MTLN bridges Nat14 and c-Jun to drive fibrotic gene expression.

   Evidence BiFC partner identification, fractionation/live imaging of translocation, collagen I promoter luciferase, T49A mutagenesis, KO and ASO fibrosis mouse models

   PMID:36804379

   Open questions at the time

   • Kinase responsible for T49 phosphorylation not identified
   • How a mitochondrial micropeptide is retargeted to the nucleus mechanistically unclear
7. 2024 High

   Extended MTLN's signaling role to cardiac growth, defining a PTPMT1–AKT axis that drives cardiomyocyte proliferation.

   Evidence MPM–PTPMT1 Co-IP, KO mouse cardiac phenotyping, RNA-seq, PTPMT1 knockdown and AKT inhibition epistasis rescues

   PMID:39163918

   Open questions at the time

   • How mitochondrial MTLN engages PTPMT1 to activate cytoplasmic AKT is undefined
   • Relationship to MTLN's metabolic functions in cardiomyocytes unclear
8. 2024 Medium

   Proposed a structural basis for MTLN function, showing it self-associates into likely hexameric pore-like complexes in the mitochondrial membrane.

   Evidence Endogenous–tagged Co-IP, native PAGE (~66 kDa complex), structure modeling, in vitro oligomerization of synthetic protein (preprint)

   PMID:bio_10.1101_2024.07.10.601956

   Open questions at the time

   • Hexameric model not validated at atomic resolution
   • Functional consequence of pore formation (e.g. transport, partner scaffolding) not demonstrated
   • Preprint, not peer-reviewed

• It remains unresolved how a single ~56-aa micropeptide integrates seemingly opposing mitochondrial activities (β-oxidation enhancement vs complex I inhibition) and switches to a distinct nuclear transcriptional role, and whether its oligomeric pore structure underlies these functions.
• Unifying biochemical mechanism linking metabolic, signaling, and transcriptional roles not established
• No high-resolution structure of MTLN in any partner complex